24/7 Wall St. on MSN
Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026
Triple-leveraged ETFs aren’t for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull ...
A report said that the family office of founders of Ajanta Pharma, which also runs other restaurant businesses, could inject ...
Sun Pharma has engaged a European bank as an advisor to structure a comprehensive financial proposal that may be presented to ...
Krystal Biotech, Inc. (NASDAQ:KRYS) is one of the best strong buy growth stocks to buy according to hedge funds. On January ...
Detailed price information for Procter & Gamble Company (PG-N) from The Globe and Mail including charting and trades.
Zacks Investment Research on MSN
Is Invesco Pharmaceuticals ETF (PJP) a strong ETF right now?
The Invesco Pharmaceuticals ETF (PJP) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer ...
Investors are eyeing a rebound in the U.S. biotech sector in 2026, as more companies are expected to go public amid a ...
Parnassus Core Select ETF (PRCS) targets 25 high-quality large-cap stocks for long-term growth. Read the full analysis for ...
Disciplined pricing, capital constraints, active M&A and adaptive regulation is setting the stage for compelling investment ...
What Happened: A Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday outlined that Tanguler executed ...
The green shoots suggesting a comeback was in sight for biotech stocks last year have mostly grown into proverbial flowering plants—but one company’s precipitous year-over-year decline in market ...
She stated that one of the significant things the last few years have taught her is that while inflation is clearly coming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results